Molecular Determinants of Acquired Clinical Resistance to Crizotinib in Non-small Cell Lung Cancer Harboring a Translocation or Inversion Event Involving the ALK Gene Locus
Clinical trial NCT01300429 · COMPLETED
Trial details
- NCT number
- NCT01300429
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-02-08
- Primary completion
- 2021-01-05
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.